OTCMKTS:LZAGY Lonza Group (LZAGY) Stock Price, News & Analysis $63.41 +0.02 (+0.03%) As of 03/28/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock About Lonza Group Stock (OTCMKTS:LZAGY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Lonza Group alerts:Sign Up Key Stats Today's Range$63.34▼$63.9850-Day Range$60.68▼$68.2052-Week Range$52.23▼$68.29Volume67,952 shsAverage Volume52,909 shsMarket Capitalization$45.80 billionP/E RatioN/ADividend Yield0.30%Price TargetN/AConsensus RatingStrong Buy Company OverviewLonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.Read More… Remove Ads Lonza Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreLZAGY MarketRank™: Lonza Group scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Lonza Group.Read more about Lonza Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth15.43% Earnings GrowthEarnings for Lonza Group are expected to grow by 15.43% in the coming year, from $1.88 to $2.17 per share.Price to Earnings Growth RatioLonza Group has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioLonza Group has a P/B Ratio of 4.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Lonza Group has been sold short.Short Interest Ratio / Days to CoverLonza Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Lonza Group has recently increased by 50.70%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldLonza Group has a dividend yield of 0.30%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthLonza Group does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Lonza Group will have a dividend payout ratio of 8.76% next year. This indicates that Lonza Group will be able to sustain or increase its dividend.Read more about Lonza Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.00% of the float of Lonza Group has been sold short.Short Interest Ratio / Days to CoverLonza Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Lonza Group has recently increased by 50.70%, indicating that investor sentiment is decreasing significantly. News and Social Media2.0 / 5News SentimentN/A News SentimentLonza Group has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Lonza Group this week, compared to 1 article on an average week.Search Interest1 people have searched for LZAGY on MarketBeat in the last 30 days. MarketBeat FollowsOnly 27 people have added Lonza Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -10% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Lonza Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.07% of the stock of Lonza Group is held by insiders.Percentage Held by InstitutionsOnly 0.04% of the stock of Lonza Group is held by institutions.Read more about Lonza Group's insider trading history. Receive LZAGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter. Email Address LZAGY Stock News HeadlinesLonza price target raised to CHF 640 from CHF 610 at RBC CapitalMarch 5, 2025 | markets.businessinsider.comLZAGF Lonza Group AGFebruary 26, 2025 | seekingalpha.comTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.March 31, 2025 | Porter & Company (Ad)Lonza Is Said to Tap BofA, Centerview for Sale of Capsules UnitFebruary 18, 2025 | bloomberg.comLonza downgraded to Equal Weight from Overweight at Morgan StanleyFebruary 13, 2025 | markets.businessinsider.comMorgan Stanley cuts Lonza stock rating, raises target to CHF625February 13, 2025 | msn.comLonza price target raised to CHF 744 from CHF 645 at Deutsche BankFebruary 3, 2025 | markets.businessinsider.comLonza price target raised to CHF 710 from CHF 630 at BarclaysFebruary 3, 2025 | markets.businessinsider.comSee More Headlines LZAGY Stock Analysis - Frequently Asked Questions How have LZAGY shares performed this year? Lonza Group's stock was trading at $58.78 at the start of the year. Since then, LZAGY stock has increased by 7.9% and is now trading at $63.41. View the best growth stocks for 2025 here. Does Lonza Group have any subsidiaries? The following companies are subsidiaries of Lonza Group: Octane Biotech, Micro-Macinazione, Capsugel, PharmaCell, InterHealth Nutraceuticals, Triangle Research Labs, Diacon Technologies, and more. How do I buy shares of Lonza Group? Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Tobacco products Sub-IndustryN/A Current SymbolOTCMKTS:LZAGY CIK1446711 Webwww.lonza.com Phone(161) 316-8111Fax41-61-316-9111Employees18,000Year Founded1897Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio33.73 P/E Growth2.01Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.45 Current Ratio1.52 Quick Ratio1.38 Sales & Book Value Annual Sales$7.47 billion Price / Sales6.13 Cash Flow$1.95 per share Price / Cash Flow32.54 Book Value$14.76 per share Price / Book4.30Miscellaneous Outstanding Shares722,262,000Free Float721,756,000Market Cap$45.80 billion OptionableNot Optionable Beta1.02 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free Report This page (OTCMKTS:LZAGY) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lonza Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Lonza Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.